Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. / Reinhard, H; Jacobsen, P Karl; Lajer, Marianne; Pedersen, N; Billestrup, N; Mandrup-Poulsen, Thomas; Parving, H-H; Rossing, P.

I: Diabetologica, Bind 53, Nr. 10, 01.10.2010, s. 2129-33.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Reinhard, H, Jacobsen, PK, Lajer, M, Pedersen, N, Billestrup, N, Mandrup-Poulsen, T, Parving, H-H & Rossing, P 2010, 'Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes', Diabetologica, bind 53, nr. 10, s. 2129-33. https://doi.org/10.1007/s00125-010-1843-4

APA

Reinhard, H., Jacobsen, P. K., Lajer, M., Pedersen, N., Billestrup, N., Mandrup-Poulsen, T., Parving, H-H., & Rossing, P. (2010). Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. Diabetologica, 53(10), 2129-33. https://doi.org/10.1007/s00125-010-1843-4

Vancouver

Reinhard H, Jacobsen PK, Lajer M, Pedersen N, Billestrup N, Mandrup-Poulsen T o.a. Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. Diabetologica. 2010 okt. 1;53(10):2129-33. https://doi.org/10.1007/s00125-010-1843-4

Author

Reinhard, H ; Jacobsen, P Karl ; Lajer, Marianne ; Pedersen, N ; Billestrup, N ; Mandrup-Poulsen, Thomas ; Parving, H-H ; Rossing, P. / Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. I: Diabetologica. 2010 ; Bind 53, Nr. 10. s. 2129-33.

Bibtex

@article{1b6f0f6927b0443f887ef638c124ae79,

title = "Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes",

abstract = "Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.",

keywords = "Angiotensin Receptor Antagonists, Aspirin, Cell Count, Cells, Cultured, Diabetes Mellitus, Type 2, Diet, Reducing, Endothelial Cells, Exercise Therapy, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Leukocytes, Mononuclear, Life Style, Male, Metformin, Stem Cells, Treatment Outcome",

author = "H Reinhard and Jacobsen, {P Karl} and Marianne Lajer and N Pedersen and N Billestrup and Thomas Mandrup-Poulsen and H-H Parving and P Rossing",

year = "2010",

month = oct,

day = "1",

doi = "10.1007/s00125-010-1843-4",

language = "English",

volume = "53",

pages = "2129--33",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "10",

}

RIS

TY - JOUR

T1 - Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

AU - Reinhard, H

AU - Jacobsen, P Karl

AU - Lajer, Marianne

AU - Pedersen, N

AU - Billestrup, N

AU - Mandrup-Poulsen, Thomas

AU - Parving, H-H

AU - Rossing, P

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.

AB - Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.

KW - Angiotensin Receptor Antagonists

KW - Aspirin

KW - Cell Count

KW - Cells, Cultured

KW - Diabetes Mellitus, Type 2

KW - Diet, Reducing

KW - Endothelial Cells

KW - Exercise Therapy

KW - Female

KW - Humans

KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors

KW - Leukocytes, Mononuclear

KW - Life Style

KW - Male

KW - Metformin

KW - Stem Cells

KW - Treatment Outcome

U2 - 10.1007/s00125-010-1843-4

DO - 10.1007/s00125-010-1843-4

M3 - Journal article

C2 - 20607514

VL - 53

SP - 2129

EP - 2133

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -

ID: 33901146